Market Research Report : Stem Cell Research Market in India 2014

3,228 views

Published on

For the complete report, get in touch with us at : info@netscribes.com

Abstract:
Netscribes latest market research report titled Stem Cell Research Market in India 2014 analyses how stem cell therapy is gaining importance in India as consumers realize the various benefits it offers. Stem cells can be used to cure a number of diseases, including cancer and neurological disorders such as Parkinsons disease, among others. The number of parents opting for stem cell storage is also rising as they want to store their babys cord blood stem cells for present and future use. Currently, the market is dominated by private banks offering stem cell storage facilities, with a few of them even reducing their prices in order to make the process more affordable for a larger number of people.
The main driving factors for this market comprise the liberal regulatory environment and the rise in the number of patients suffering from chronic diseases. Government and industry bodies are working towards developing the market by providing various incentives in this direction. With stem cell research being a capital-intensive process, the primary challenge for the market centers on the huge cost of storing stem cells. Apart from research organizations, many stem cell banks are also involved in R&D of stem cell therapy in India. New trends such as public and private partnerships and EMI schemes offered by stem cell banks are crucial future driving factors for this market.
Coverage
Overview of the stem cell research sector in India
Overview of stem cell therapy market and stem cell banking in India and historical and forecasted market size data over FY 2013 to FY 2018e
Overview of the various sources of stem cells and their application
Analyses the value chain of stem cell research as well as the average prices charged by the stem cell banks
Qualitative analysis of market drivers, challenges, government participation and key trends
Analysis of the competitive landscape and detailed profiles of major players as well as the research organizations
Overview of the strategic recommendation

Published in: Business, Technology
1 Comment
1 Like
Statistics
Notes
  • Nice PPT. The way of explanation about ppt is good. Thanks for sharing the information. Visit : http://is.gd/smkRWm
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total views
3,228
On SlideShare
0
From Embeds
0
Number of Embeds
102
Actions
Shares
0
Downloads
138
Comments
1
Likes
1
Embeds 0
No embeds

No notes for slide

Market Research Report : Stem Cell Research Market in India 2014

  1. 1. Insert Cover Image using Slide Master View Do not distort Stem Cell Research Market – India June 2014
  2. 2. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE 2 Executive Summary Market Drivers & Challenges Trends Competition • The Stem Cell Therapy market in India was valued at INR x1 bn in 2013 which is expected to reach INR x2 bn approximately by the year 2018 • The Cord Blood Cell Banking Market was worth INR y1 bn in 2013 and is expected to reach INR y2 bn by the year 2018 • India is projected to see a rise in the number of stem cell banks and stem cell depositors in the near future •Increasing partnerships •Increasing investments • Efforts to increase awareness in stem cell banking • Easy financing opportunities in stem cell banking Major Players Stem Cell Banks Company A Company B Company C Stem Cell Research Organizations Organization A Organization B Organization C Challenges • High Cost of Therapy • Capital intensive nature of research is decelerating the market • ‘Development Costs’ of Stem Cell therapy resulting in slow progress of the market Drivers: • Favorable Regulatory Environment • High Patient Population • Application in Drug Development • Increasing Awareness • Growing Medical Tourism • Increasing Health related Expenditure
  3. 3. STEM CELL RESEARCH IN INDIA 2014.PPT 3 •Macroeconomic Indicators •Introduction •Market Overview •Drivers & Challenges •Market Value Chain •Market Trends •Potential Stem Cell Sources •Government Participation •Competition Stem Cell Banks Research Organizations •Recent Developments •Strategic Recommendations •Appendix
  4. 4. STEM CELL RESEARCH IN INDIA 2014.PPT Economic Indicators (1/3) 11 12 13 14 15 b2 a2 Q1 d1 c1 b1 a1 Q4 c4 b4 a4 Q3 c3 b3 a3 Q2 d2 c2 INR tn 2013-142012-132011-122010-11 GDP at Factor Cost: Quarterly Inflation Rate: Monthly -2 -1 0 1 2 q Jul 2013 - Aug 2013 p % Nov 2013 - Dec 2013 t Oct 2013 - Nov 2013 s Sep 2013 - Oct 2013 r Aug 2013 - Sep 2013
  5. 5. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE Research supply companies are expected to earn huge profits by producing stem cells research products • The global stem cell research sector is expected to grow at a rate of x1% due to a number of reasons  Liberalization of stem cell research and government support due to the rise in the incidence of chronic diseases are the major factors aiding growth • USA and China have the highest volume of stem cell research and Singapore, Italy, USA, Japan, and Israel have the highest level of activity in this area • Globally, there are x2 companies involved in different areas of stem cells research and the number is expected to grow at a rate of x3% – x4% • Well defined guidelines for stem cell research and therapy have been developed by the US FDA & EMEA while the South Asian / South East Asian countries are yet to develop guidelines in this field Global Market – Overview Stem Cell Therapy – Market Size and Growth t s r q p INR bn X% 2018e a6 2017e a5 2016e a4 2015e a3 2014e a2 2013 a1 u t s r q p Nos. Y% 2013 x2 2005 x1 Number of Stem Cell Banks Worldwide
  6. 6. STEM CELL RESEARCH IN INDIA 2014.PPT Stem cell therapy market is poised to grow at a very high rate due to increasing therapeutic applications • The Stem Cell Therapy market in India was valued at INR x1 units in 20-- • The market is expected to reach INR x6 units approximately by 20--, growing at a CAGR of X% for this time period • The stem cell research is a key factor that propels the therapeutic market • Almost m stem cell transplants are carried out in India annually that is growing gradually Stem Cell Therapy Market – Overview Market Size and Growth s r q p 0 INR units X% 20--e x6 20--e x5 20--e x4 20--e x3 20--e x2 20-- x1 20-- x0 • The Stem Cell Banking Market was worth INR y1 units in 20-- and is expected to reach INR y6 units in 20-- • The stem cell banking market is expected to exhibit a CAGR of Y% between 20-- and 20-- • Stem cell banking that was unheard of a few years back but has become popular in the recent past as a less traumatic alternative to treat neurological diseases and as guarantee for the entire family against several other diseases Stem Cell Banking Market – Overview t s r q p 0 20-- y0 INR units Y% 20--e y6 20--e y5 20--e y4 20--e y3 20--e y2 20-- y1 Market Size and Growth
  7. 7. STEM CELL RESEARCH IN INDIA 2014.PPT 7 Drivers & Challenges – Summary Drivers Favorable Regulatory Environment High Patient Population Application in Drug Development Increasing Awareness Growing Medical Tourism Increasing R&D Expenditure Challenges High Cost of Therapy Capital Intensive Market High Development Cost
  8. 8. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE 8 Easy financing opportunities in stem cell banking Increasing Partnerships Efforts to increase awareness in stem cell Increasing Investments Key Trends Trends – Summary
  9. 9. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLEPorter’s Five Forces Analysis Competitive RivalryBargaining Power of Suppliers Bargaining Power of Buyers Threat of Substitutes Threat of New Entrants Impact x Impact x Impact x Impact x Impact x *Note: BEP (Break-even point)
  10. 10. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLEKey Ratios of Top 3 Companies – Operational Basis (FY 2013) (1/3) Competitive Benchmarking (2/5) 0 10 20 30 40 % Company C b3a3 Company B b2a2 Company A b1 a1 Operating Margin Net Margin • Company A recorded operating margin of x1%, higher than that of Company B which recorded operating margin of y2% but lower than that of Company C which recorded operating margin of z3% • Net margin for Company A , Company B and Company C are a1%, b2% and c3% respectively, wherein Company A has the highest net margin among these three companies
  11. 11. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE Public: Domestic Company – Company 1 (1/5) Key People Products and Services Company Information Offices and Centres – India Corporate Address Tel No. Fax No. Website Year of Incorporation Ticker Symbol Stock Exchange Name Designation Person 1 MD and Executive Director Person 2 VC and VC of Share Transfer Committee Person 3 Director Person 4 Director Head OfficeMumbai Category Products/Services
  12. 12. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLEFinancial Snapshot Key Ratios Financial Summary • The company earned a net profit of INR x1 mn in FY 2013, as compared to net profit of INR x2 mn in FY 2012 • The company reported total income of INR y1 mn in FY 2013, registering an increase of y2% over FY 2012 • The company earned an operating margin of z1% in FY 2013, an increase of z2percentage points over FY 2012 • The company reported debt to equity ratio of a1 in FY 2013, an increase of a3% over FY 2012 Key Financial Performance Indicators Indicators Value (20/03/2014) Particulars y-o-y change (2013-12) 2013 2012 2011 2010 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Improved Decline Net Profit/LossTotal Income e d c b a s r q p 2013 a4 z4 2012 a3 z3 2011 a2 z2 2010 a1 z1 Public: Domestic Company – Company 1 (2/5)
  13. 13. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE Public: Domestic Company – Company 1 (3/5) Key Business Segments Key Geographic Segments A% B% C% 2013 b4% 2012 b3% 2011 b2% 2010 b1% a1% C% B% A% 2010 y1% x1% 2013 x4% 2012 x3% 2011 x2% Region 2Region 1 Business Highlights Segment 2Segment 1 Description News Overview • The company has operations in Country A, Country B and Country C that offers treatment for acute and chronic diseases in primary, secondary and tertiary care sectors Services • Specializes in 50 specialties comprising cardiac sciences, oncology, radiology and imaging, gastroenterology, neurosciences, orthopedics, critical care services and in minimally invasive surgeries and transplantation • Operates retail pharmacy outlets all across the country
  14. 14. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE TO WS Public: Domestic Company – Company 1 – SWOT Analysis (5/5)
  15. 15. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE Private: Domestic Company – Company 2 (1/5) Key People Products and Services Company Information Offices and Centres – India Name Designation Person 1 Director Person 2 Director Person 3 Director Person 4 Director Corporate Address Tel No. Fax No. Website Year of Incorporation Head Office Category Products/Services Ready Meals Instant Mixes Others Mumbai
  16. 16. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE Private: Domestic Company – Company 2 (2/5) Shareholders of the Company Ownership Structure Name No. of Shares held 23.6% 57.4% 19.0% Segment Segment Segment
  17. 17. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE READY TO EAT MARKET IN INDIA 2014.PPT Financial Snapshot Key Ratios Particulars y-o-y change (2013-12) 2013 2012 2011 2010 Profitability Ratios Operating Margin Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover Working Capital Turnover Capital Employed Turnover Private: Domestic Company – Company 2 (3/5) Improved Decline Financial Summary • The company earned a net profit of INR x1 mn in FY 2011, as compared to net profit of INR x2 mn in FY 2010 • The company reported total income of INR x3 mn in FY 2011, registering an increase of x4% over FY 2010 • The company earned an operating margin of x5% in FY 2011, an increase of x6 percentage points over FY 2010 • The company reported debt to equity ratio of x7 in FY 2011, a decrease of x8% over FY 2010 Net Profit/LossTotal Income a t s r q f p b c d e b4 a4 20112008 a1 b1 2010 a3 b3 2009 a2 b2
  18. 18. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE 18 Description News Overview • Company 2 has hospital network in Country A, Country B and Country C and is primarily headquartered in Country D • Presently located in 10 cities in India having hospitals in Region 1, Region 2 and Region 3 Facilities • Has core specialties in heart care, brain and spine, bone and joint and minimal access surgery • Provides advanced medical diagnostics and treatment with personal care Recognitions • Obtained NABH accreditation within one and a half years of beginning operation in India • Hospital A, Region 1, Hospital B, Region 2 has been NABH accredited Business Highlights Private: Domestic Company – Company 2 (3/5)
  19. 19. STEM CELL RESEARCH IN INDIA 2014.PPT SAMPLE TO WS Private: Domestic Company – Company 2– SWOT Analysis (5/5)
  20. 20. STEM CELL RESEARCH IN INDIA 2014.PPT Thank you for the attention About Netscribes, Inc. Netscribes, Inc. is a knowledge-consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of investment & business research, business & corporate intelligence, content-management services, and knowledge-software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one-stop shop designed to fulfil clients’ profitability and growth objectives. Stem Cell Research Market in India 2014– India report is part of Netscribes’ Healthcare Series. For any queries or customized research requirements, contact us at: Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, “Netscribes” is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction. Phone: +91 22 4098 7600 E-Mail: info@netscribes.com

×